Artificial intelligence may be the key in helping doctors determine which patients with intermediate AMD are at a high risk of the disease progressing to geographic atrophy.
age-related macular degeneration
Researchers concluded that anti-VEGF treatments do raise the risk of glaucoma progression.
Researchers compared the visual outcomes and rate of intraoperative complications in patients with nAMD and control eyes that did not have nAMD that underwent phacoemulsification cataract surgery o...
Researchers discovered that levodopa is safe, well-tolerated and not only improved visual outcomes but also delayed anti-VEGF injections.